ICAI Issues “Technical Guide on Internal Audit of Pharmaceutical Industry”
- Blog|News|Account & Audit|
- < 1 minute
- By Chetan Kulasri
- |
- Last Updated on 12 October, 2023
Latest from Taxmann
The major challenges that are being faced by the Indian pharmaceutical companies includes regulatory compliances, Intellectual Property Rights Issues, price controls, innovation and infrastructure challenge, skilled workforce, global competition. Internal audit can be considered as a best tool to overcome such challenges. Therefore, in order to provide guidance to internal auditors in carrying out internal audit of companies operating in pharmaceutical industry a “Technical Guide on Internal Audit of Pharmaceutical Industry” has been issued by ICAI.
Click Here To Read The Full Update
Disclaimer: The content/information published on the website is only for general information of the user and shall not be construed as legal advice. While the Taxmann has exercised reasonable efforts to ensure the veracity of information/content published, Taxmann shall be under no liability in any manner whatsoever for incorrect information, if any.
CA | CS | CMA
